News and Comments

Good News for Agenus and for Global Blood Therapeutics

  Friday, June 10, 2016

Agenus (AGEN) announced that a lead product candidate is selected under its license and research collaboration with Merck, which is known as MSD outside the United States and Canada.   More...


  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

Recent Postings



RenenxBio (RGNX) Galena (GALE) Valeant Pharmaceuticals International (VRX) Aimmune Therapeutics (AIMT) Sangamo (SGMO) PTC Therapeutics (PTCT) Anadys (ANDS) Telaprevir TOKAI (TKAOI) Agenus (AGEN Auspex (ASPX) BIOMARIN (BMRN) Intrexon (XON) VANDA (VNDA) AGOS (ARGS) galapagos (GLPG) Xoma (XOMA) Amgen (AMGN) Alder Biopharmaceuticals (ALDR) Illumina (ILMN) Pluristem (PSTI) HALOZYME (HALO) Ionis (IONS) Intermune (ITMN) ImmunoGen (IMGN) KERYX (KERX) Global Cell Therapeutics (GBT) ARCA (ABIO) Ziofpharm (ZIOP) Sanofi (SNY) Abbott Laboratories (ABT) Advaxis (ADXS) Ariad (ARIA) Benlysta (belimumab) Human Longevity (HLI) Ridaforolimus AERIE PHARMACEUTICALS Sanofi (SNA) GUARDIAN HEALTH Revlimid (lenolidamide) ACADIA (ACAD) Incyte (INCY) Herceptin Regeneron (REGN) Velcade (bortezomib) CompuGen (CGEN) KITE (KITE) Dynavax (DVAX) SUNESIS PHARMACEUTICALS (SNSS) Vertex (VRTX) Roche (ROCHE) Human Genome Sciences (HGSI) Prolor Biotech (PBTH) Roche (RHHBY) Genentech Tysabri Array Pharmaceuticals (ARRY) ADVENTRIX (ANX) Biogen Idec (BIIB) Sanofi-Aventis (SAN) ABBVIE (ABBV) Micromet (MITI) Rapamune Agenus (AGEN) NEKTAR (NKTR)) Intercept (ICPT) Onyx (ONXX) SYNTA (SNTA) Cytokinetics (CYTK) Prosensa (RNA) Editas (EDIT) Elan (ELN) Theravance (THRX) Theravance Bio Pharma (TBPH) Dendreon (DNDN) OSI (OSIP) Anacor (ANAC) Zerenex JUNO (JUNO) AstraZeneca (AZN) MODERNA C4 Therapeutics Trastuzumab-DM1 Biocryst (BCRX) ISIS (ISIS) Sarepta (SRPT) Jazz Pharmaceuticals (JAZZ) Mirati Therapeutics (MRTX) IDERA (IDRA) NOVOCURE (NVCR) SERES THERAPEUTICS (MCRB) REGULUS (RGLS) Bellicum (BLCM) Multiple Myeloma GlaxoSmithKline (GSK) Alnylam (ALNY) Idenix (IDIX) Bristol-Myers Squibb (BMY) ZALTRAP™ Sequenom (SQNM) NANTKWEST (NK) Spike Therapeutics (ONCE) Gilead (GILD) ARGOS (ARGS) Seattle Genetics (SGEN) Inovio (INO) Endometrial Cancer Exelixis (EXEL) INNOVIVA (INVA) Vitae Pharmaceuticals (VTAE) Adaptimmune (ADAP) Merck (MRK)